Progress in Molecular Biology and Translational Science最新文献_第6页

Phages for treatment of Escherichia coli infections. 用于治疗大肠杆菌感染的噬菌体。

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2023-01-01 Epub Date: 2023-06-17 DOI: 10.1016/bs.pmbts.2023.03.011

Nikita Nikulin, Alexandra Nikulina, Andrei Zimin, Rustam Aminov

{"title":"Phages for treatment of Escherichia coli infections.","authors":"Nikita Nikulin, Alexandra Nikulina, Andrei Zimin, Rustam Aminov","doi":"10.1016/bs.pmbts.2023.03.011","DOIUrl":"https://doi.org/10.1016/bs.pmbts.2023.03.011","url":null,"abstract":"Diseases due to infections by pathogenic Escherichia coli strains are on the rise and with the growing antimicrobial resistance among bacterial pathogens, including this group. Thus, alternative therapeutic options are actively investigated. Among these alternatives is phage therapy. In the case of E. coli, the combination of the well understood biology of this species and its bacteriophages represents a good guiding example for the establishment of phage therapy principles against this and other pathogenic bacteria. In this chapter, the procedures toward the development of phage therapy against pathogenic E. coli with the use of T-even group of phages are discussed. These steps involve the isolation, purification, characterisation and large-scale production of these phages, with formulation of phage cocktails for in vitro and in vivo studies. The main emphasis is made on phage therapy of enteropathogenic E. coli O157:H, which is one of the prominent human pathogens but persists as a commensal bacterium in many food animals. The implementation of phage therapy against E. coli O157:H within the One Health framework in carrier animals and for treatment of meat, vegetables, fruits and other agricultural produce thus would allow controlling and interrupting the transmission routes of this pathogen to the human food chain and preventing human disease. Examples of successful control and elimination of E. coli O157:H are given, while the problems encountered in phage treatment of this pathogen are also discussed.","PeriodicalId":49280,"journal":{"name":"Progress in Molecular Biology and Translational Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41169459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bacteriophage as cargo and its application in nanomedicine. 噬菌体及其在纳米医学中的应用。

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2023-01-01 Epub Date: 2023-04-20 DOI: 10.1016/bs.pmbts.2023.03.024

Vishnu Kirthi Arivarasan, Chitrakshi Consul

{"title":"Bacteriophage as cargo and its application in nanomedicine.","authors":"Vishnu Kirthi Arivarasan, Chitrakshi Consul","doi":"10.1016/bs.pmbts.2023.03.024","DOIUrl":"https://doi.org/10.1016/bs.pmbts.2023.03.024","url":null,"abstract":"Bacteriophages are viruses that infect the bacteria. However, different studies conducted on the same display a wide range of applications in terms of therapeutic purposes. The structure of a bacteriophage includes the head (site for the storage of its genetic material) and a tail (serves the purpose of detection, ligand-receptor binding and insertion of the genetic material into the host organism). The head being a storehouse of genetic material, the contents of the same are often manipulated for therapeutic purposes. In some cases, these bacteriophages are modified as virus like particles (VLPs), which are employed as carriers for transportation of the desired components to the target site, thereby being reliable alternatives for therapeutic purposes. The distinctive properties of these VLPs include their biocompatibility, abundant space for accommodation of desired components, bio processivity, target specificity, does not interfere with the on-going metabolic processes; thereby being agents of choice for various therapeutic purposes. The bacteriophages play significant roles in delivery of certain components thereby enhancing their therapeutic applications. These include biomolecules such as enzymes, peptide-based drugs, CRISPR along with others. Apart from this, bacteriophage targeted delivery has also shown promising results in cancer treatments and vaccination strategies. Bacteriophages are therefore, promising delivery agents and can be opted for delivery of either single or combination of compounds in future treatment strategies.","PeriodicalId":49280,"journal":{"name":"Progress in Molecular Biology and Translational Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41122516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Phage therapy in gut microbiome. 肠道微生物组的噬菌体疗法。

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2023-01-01 Epub Date: 2023-05-02 DOI: 10.1016/bs.pmbts.2023.04.005

Xingyao Chen, Beatriz G Mendes, Bruno Secchi Alves, Yi Duan

{"title":"Phage therapy in gut microbiome.","authors":"Xingyao Chen, Beatriz G Mendes, Bruno Secchi Alves, Yi Duan","doi":"10.1016/bs.pmbts.2023.04.005","DOIUrl":"10.1016/bs.pmbts.2023.04.005","url":null,"abstract":"Phage therapy, the use of bacteriophage viruses for bacterial infection treatment, has been around for almost a century, but with the increase in antibiotic use, its importance has declined rapidly. There has been renewed interest in revisiting this practice due to the general decline in the effectiveness of antibiotics, combined with improved understanding of human microbiota and advances in sequencing technologies. Phage therapy has been proposed as a clinical alternative to restore the gut microbiota in the absence of an effective treatment. That is due to its immunomodulatory and bactericidal effects against its target bacteria. In the gastrointestinal diseases field, phage therapy has been studied mainly as a promising tool in infectious diseases treatment, such as cholera and diarrhea. However, many studies have been conducted in non-communicable diseases, such as the targeting of adherent invasive Escherichia coli in Crohn's disease, the treatment of Clostridioides difficile in ulcerative colitis, the eradication of Fusobacterium nucleatum in colorectal cancer, the targeting of alcohol-producing Klebsiella pneumoniae in non-alcoholic fatty liver disease, or Enterococcus faecalis in alcohol-associated hepatitis. This review will summarize the changes in the gut microbiota and the phageome in association with some gastrointestinal and liver diseases and highlight the recent scientific advances in phage therapy as a therapeutic tool for their treatment.","PeriodicalId":49280,"journal":{"name":"Progress in Molecular Biology and Translational Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41155688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Phage for regenerative medicine and cosmetics. 再生医学和化妆品的噬菌体。

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2023-01-01 Epub Date: 2023-04-06 DOI: 10.1016/bs.pmbts.2023.03.017

Nhat-Le Bui, Mai Anh Nguyen, Manh-Long Nguyen, Quoc-Cuong Bui, Dinh-Toi Chu

{"title":"Phage for regenerative medicine and cosmetics.","authors":"Nhat-Le Bui, Mai Anh Nguyen, Manh-Long Nguyen, Quoc-Cuong Bui, Dinh-Toi Chu","doi":"10.1016/bs.pmbts.2023.03.017","DOIUrl":"https://doi.org/10.1016/bs.pmbts.2023.03.017","url":null,"abstract":"Phage or bacteriophage is a specific virus with the ability to defeat bacteria. Because of the rising prevalence of antimicrobial-resistant bacteria, the bacteriophage is now receiving interest again, with it application in skin infection or acne treatment. Moreover, bacteriophages also express their efficacy in wound healing or skin regeneration. Thanks to the development of bioengineering technology, phage display, which is a technique using bacteriophage as a tool, has recently been applied in many biotechnological and medical fields, especially in regenerative medicines. Bacteriophages can be used as nanomaterials, delivery vectors, growth factor alternatives, or in several bacteriophage display-derived therapeutics and stem cell technology. Although bacteriophage is no doubt to be a potential and effective alternative in modern medicine, there are still controversial evidence about the antibacterial efficacy as well as the affinity to expected targets of bacteriophage. Future mission is to optimize the specificity, stability, affinity and biodistribution of phage-derived substances. In this chapter, we focused on introducing several mechanisms and applications of bacteriophage and analyzing its future potential in regenerative medicines as well as cosmetics via previous research's results.","PeriodicalId":49280,"journal":{"name":"Progress in Molecular Biology and Translational Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41167414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Human Microbiome in Health and Disease - Part B 健康和疾病中的人类微生物组- B部分

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2022-01-01 DOI: 10.1016/s1877-1173(22)x0008-2

引用次数: 0

Micro/Nanofluidics and Lab-on-Chip Based Emerging Technologies for Biomedical and Translational Research Applications - Part B 微/纳米流体和基于芯片实验室的生物医学和转化研究应用新兴技术- B部分

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2022-01-01 DOI: 10.1016/s1877-1173(22)x0003-3

引用次数: 0

Molecular Biology and Clinical Medicine in the Age of Politicization 政治化时代的分子生物学与临床医学

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2022-01-01 DOI: 10.1016/s1877-1173(22)x0004-5

引用次数: 1

Large Animals as Models for Human Diseases 作为人类疾病模型的大型动物

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2022-01-01 DOI: 10.1016/s1877-1173(22)x0005-7

引用次数: 0

Index 指数

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2021-01-01 DOI: 10.1016/s1877-1173(21)00196-4

引用次数: 0

Advances in Aggregation Induced Emission Materials in Biosensing and Imaging for Biomedical Applications - Part B 聚集诱导发射材料在生物医学应用生物传感和成像中的研究进展——B部分

3区生物学

Progress in Molecular Biology and Translational Science Pub Date : 2021-01-01 DOI: 10.1016/s1877-1173(21)x0010-5

引用次数: 1